Severe COVID-19 is characterized by excessive inflammation of the lower airways. The
balance of protective versus pathological immune responses in COVID-19 is incompletely …

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a global pandemic. …

Since the outset of the COVID-19 pandemic, increasing evidence suggests that the innate
immune responses play an important role in the disease development. A dysregulated …

Objectives The role of innate lymphoid cells (ILCs) in coronavirus disease 2019 (COVID‐19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is unknown. …

Objectives Humoral and cellular immunity to SARS‐CoV‐2 following COVID‐19 will likely
contribute to protection from reinfection or severe disease. It is therefore important to …

We evaluated the performance of 11 SARS-CoV-2 antibody tests using a reference set of
heat-inactivated samples from 278 unexposed persons and 258 COVID-19 patients, some of …

SEMA4D/CD100 is a homodimeric protein belonging to the semaphorin family of axonal
guidance proteins. Semaphorin family members have received increased attention lately due to …

Objective The COVID‐19 pandemic poses an immense need for accurate, sensitive and
high‐throughput clinical tests, and serological assays are needed for both overarching …

Background COVID-19 remains a major public health challenge, requiring the development
of tools to improve diagnosis and inform therapeutic decisions. As dysregulated …

Background Hantavirus pulmonary syndrome (HPS) is caused by Andes virus (ANDV) and
related hantaviruses in the Americas. Despite a fatality rate of 40%, the pathogenesis of HPS …